About 3 700 reports

Global Parkinsons Disease Drug Market Research Report 2016

114 pages • By QY Research

Notes:Production, means the output of Parkinsons Disease DrugRevenue, means the sales value of Parkinsons Disease DrugThis report studies Parkinsons Disease Drug in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production,...

2 320 2 900 1 856
Sep 2016

Global Tartaric Acid For Pharmaceutical Market Research Report 2016

105 pages • By QY Research

Notes:Production, means the output of Tartaric Acid For PharmaceuticalRevenue, means the sales value of Tartaric Acid For PharmaceuticalThis report studies Tartaric Acid For Pharmaceutical in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global...

2 320 2 900 1 856
Sep 2016

Croatia Pharmaceuticals and Healthcare Report Q4 2016

78 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Continued political instability coupled with a bleak economic outlook will continue to repressthe pharmaceutical and healthcare sectors in Croatia. Necessary austerity measures will impose furtherbarriers towards growth and reduce the use of high-value patented drugs,...

985 1 300 818
Sep 2016

Hungary Pharmaceuticals and Healthcare Report Q4 2016

83 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: The Hungarian government's fiscal stimulus initiatives will boost the private consumption ofpharmaceuticals, particularly the over the counter medicines segment. A secondary set of initiatives areaimed at increasing domestic production capabilities, such as the pharmaceutical...

985 1 300 818
Sep 2016

Iran Pharmaceuticals and Healthcare Report Q4 2016

98 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: The removal of economic sanctions heralds an era of uncertainty for Iran's pharmaceuticalmarket. Underlying issues regarding the operating environment will prevent an immediate uptick inmultinational drugmaker interest; rather, this will be a gradual process. Nevertheless,...

985 1 300 818
Sep 2016

Australia Pharmaceuticals and Healthcare Report Q4 2016

98 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: The incumbent Liberal-National coalition's victory in Australia's federal elections will not bringabout a clear policy direction for the healthcare sector. While the government has a fresh mandate to enactits policies, it is considerably weaker from the previous election...

985 1 300 818
Sep 2016

Ireland Pharmaceuticals and Healthcare Report Q4 2016

75 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: The Irish government's four-year agreement with the pharmaceutical industry with regard todrug pricing reflects the government's continued focus on cost control measures targeting pharmaceuticalexpenditure. The agreed price-reduction mechanism for existing medicines will,...

985 1 300 818
Sep 2016

United States Nanopharmaceuticals Industry 2016 Market Research Report

136 pages • By QY Research

The United States Nanopharmaceuticals Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Nanopharmaceuticals industry.The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Nanopharmaceuticals market...

3 040 3 800 2 432
Sep 2016

Global Pharmaceutical Excipients Sales Market Report 2016

127 pages • By QY Research

Notes:Sales, means the sales volume of Pharmaceutical ExcipientsRevenue, means the sales value of Pharmaceutical ExcipientsThis report studies sales (consumption) of Pharmaceutical Excipients in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries,...

3 200 4 000 2 560
Sep 2016

Global Levodopa Market Research Report 2016

104 pages • By QY Research

Notes:Production, means the output of LevodopaRevenue, means the sales value of LevodopaThis report studies Levodopa in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer,...

2 320 2 900 1 856
Sep 2016

Global Hexyl Alcohol Market Research Report 2016

114 pages • By QY Research

Notes:Production, means the output of Hexyl AlcoholRevenue, means the sales value of Hexyl AlcoholThis report studies Hexyl Alcohol in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and...

2 320 2 900 1 856
Sep 2016

Global Genitourinary Drugs Market Research Report 2016

106 pages • By QY Research

Notes:Production, means the output of Genitourinary DrugsRevenue, means the sales value of Genitourinary DrugsThis report studies Genitourinary Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue...

2 320 2 900 1 856
Sep 2016

Europe Zambia Pharmaceutical Market Report 2016

123 pages • By QY Research

Notes:Sales, means the sales volume of Zambia PharmaceuticalRevenue, means the sales value of Zambia PharmaceuticalThis report studies sales (consumption) of Zambia Pharmaceutical in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales,...

3 120 3 900 2 496
Sep 2016

Chemical and Pharmaceutical Plants Construction in Indonesia to 2020: Market Databook

33 pages • By Timetric

SynopsisTimetric’s 'Chemical and Pharmaceutical Plants Construction in Indonesia to 2020: Market Databook' contains detailed historic and forecast market value data for the chemical and pharmaceutical plants construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance,...

400 500 320
Sep 2016

Chemical and Pharmaceutical Plants Construction in Slovenia to 2020: Market Databook

33 pages • By Timetric

SynopsisTimetric’s 'Chemical and Pharmaceutical Plants Construction in Slovenia to 2020: Market Databook' contains detailed historic and forecast market value data for the chemical and pharmaceutical plants construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance,...

400 500 320
Sep 2016

Chemical and Pharmaceutical Plants Construction in Spain to 2020: Market Databook

33 pages • By Timetric

SynopsisTimetric’s 'Chemical and Pharmaceutical Plants Construction in Spain to 2020: Market Databook' contains detailed historic and forecast market value data for the chemical and pharmaceutical plants construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance, refurbishment...

400 500 320
Sep 2016

Global Ibuprofen Sales Market Report 2016

121 pages • By QY Research

Notes:Sales, means the sales volume of IbuprofenRevenue, means the sales value of IbuprofenThis report studies sales (consumption) of Ibuprofen in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market...

3 200 4 000 2 560
Sep 2016

China Povidone Iodine (PVP-I) Industry 2016 Market Research Report

138 pages • By QY Research

The China Povidone Iodine (PVP-I) Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Povidone Iodine (PVP-I) industry.The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Povidone Iodine (PVP-I)...

2 560 3 200 2 048
Sep 2016

Global Oxidative Stress Detection Market 2016-2020

72 pages • By Infiniti Research Limited

About Oxidative StressOxidative stress is a state of imbalance caused in cells when a free radical or a reactive oxygen species takes an electron from a molecule and causes a chain reaction leading to cell and tissue damage. Oxidative stress is common in all living organisms and is acceptable to a certain level, beyond which it leads...

2 000 2 500 1 600
Sep 2016

United States 6-Aminopenicillin Acid (6-APA) Industry 2016 Market Research Report

133 pages • By QY Research

The United States 6-Aminopenicillin Acid (6-APA) Industry 2016 Market Research Report is a professional and in-depth study on the current state of the 6-Aminopenicillin Acid (6-APA) industry.The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The 6-Aminopenicillin...

3 040 3 800 2 432
Sep 2016

Global Intrauterine Contraceptive Devices Market Research Report 2016

101 pages • By QY Research

Notes:Production, means the output of Intrauterine Contraceptive DevicesRevenue, means the sales value of Intrauterine Contraceptive DevicesThis report studies Intrauterine Contraceptive Devices in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers...

2 320 2 900 1 856
Sep 2016

Singapore Pharmaceuticals and Healthcare Report Q4 2016

104 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: The delivery of healthcare in Singapore will continue to change as the country looks to deepenthe integration of technology with its medical sector. This will see a shift in the flow of patients seekingmedical services, their interaction with physicians and potentially...

985 1 300 818
Sep 2016

Puerto Rico Pharmaceuticals and Healthcare Report Q4 2016

91 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: An expected increase in US government funding to strengthen Puerto Rico's healthcare systemwill support pharmaceutical and healthcare sector growth in the commonwealth over the next few years.While the US administration will continue to seek legislative removal of Puerto...

985 1 300 818
Sep 2016

Pakistan Pharmaceuticals and Healthcare Report Q4 2016

108 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Pakistan's pharmaceutical market will remain a low priority for innovative drugmakers.Downward price pressures on pharmaceutical prices coupled with uncertainty surrounding the country'spolicy direction impinge on potential commercial opportunities, while a fragmented...

985 1 300 818
Sep 2016

Sweden Pharmaceuticals and Healthcare Report Q4 2016

98 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Declining government reimbursement for prescription medicines and the promotion of lowervaluegeneric medicines does not bode well for innovative drugmakers selling their products in Sweden,particularly as the government is the primary purchaser of pharmaceuticals. Over...

985 1 300 818
Sep 2016

Serbia Pharmaceuticals and Healthcare Report Q4 2016

81 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Serbia will remain an unattractive market for multinational drugmakers in comparison to itsregional neighbours. Government cost-containment, via severe drug price cuts, and continued economicissues will dampen the country's growth outlook.Headline Expenditure...

985 1 300 818
Sep 2016

Switzerland Pharmaceuticals and Healthcare Report Q4 2016

76 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Switzerland will remain amongst the wealthiest countries in the world in real GDP per capitaterms, which together with an aging population and a preference for patented medicines, will keeppharmaceutical spending high. However, faced with growing healthcare costs, the...

985 1 300 818
Sep 2016

Iraq Pharmaceuticals and Healthcare Report Q4 2016

68 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Iraq's ailing domestic landscape will dampen investor confidence in the country'spharmaceuticals and healthcare sectors over at least the next few years if not longer. Although thegovernment remains committed to healthcare provision, economic and security headwinds will...

985 1 300 818
Sep 2016

Sudan and South Sudan Pharmaceuticals and Healthcare Report Q4 2016

59 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Economic and political challenges will continue to undermine growth within Sudan and SouthSudan's pharmaceutical and healthcare markets. As such, political instability will remain a barrier to anysignificant investment in the sector, whilst disagreements about oil revenue...

985 1 300 818
Sep 2016

Oman Pharmaceuticals and Healthcare Report Q4 2016

75 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: The Oman Ministry of Health's decision to postpone the latest phase of medicine pricereductions highlights the opaque nature of the country's pharmaceutical sector. Over the long term, Oman'spopulation will benefit from more affordable healthcare services as even more...

985 1 300 818
Sep 2016